These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 95625)

  • 21. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
    Gómez R; Lima I; Simón C; Pellicer A
    Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of human anti-luteinizing hormone-releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH.
    Lindner J; McNeil LW; Marney S; Conway M; Rivier J; Vale W; Rabin D
    J Clin Endocrinol Metab; 1981 Feb; 52(2):267-70. PubMed ID: 7007403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homologous regulation of hormone receptors: luteinizing hormone increases its own receptors in cultured rat granulosa cells.
    Jia XC; Hsueh AJ
    Endocrinology; 1984 Dec; 115(6):2433-9. PubMed ID: 6094158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of ovulation by LH and FSH in the presence of antigonadotrophic sera.
    Schwartz NB; Cobbs SB; Talley WL; Ely CA
    Endocrinology; 1975 May; 96(5):1171-8. PubMed ID: 1122881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic induction of ovulation: towards the replacement of hCG with LH].
    Emperaire JC
    Contracept Fertil Sex; 1994; 22(7-8):459-67. PubMed ID: 7920947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
    Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
    J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antigenic structure of the human glycoprotein hormone alpha-subunit. I. Characterization of anti-alpha monoclonal antibodies.
    Charlesworth MC; McCormick DJ; Bergert ER; Vutyavanich T; Hojo H; Ryan RJ
    Endocrinology; 1990 Dec; 127(6):2977-84. PubMed ID: 1701133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of anti luteinizing hormone releasing factor (LH-RF) serum: immunological application and development of radioimmunoassay.
    Shiina M
    Nihon Funin Gakkai Zasshi; 1976 Oct; 21(4):12-21. PubMed ID: 12158548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of salmon gonadotropin-releasing hormone on follicle stimulating hormone secretion and subunit gene expression in coho salmon (Oncorhynchus kisutch).
    Dickey JT; Swanson P
    Gen Comp Endocrinol; 2000 Jun; 118(3):436-49. PubMed ID: 10843795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nature of cross-reaction between hCG and anti-oLH serum and development of a radioimmunoassay to measure hLH specifically in the presence of hCG.
    Dattatreyamurty B; Sheth AR; Purandare TV; Rao SS
    Endocrinology; 1976 Dec; 99(6):1554-61. PubMed ID: 63368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the "sweet spot" for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect against a clinically significant late follicular increase in progesterone: an analysis of 10,280 first in vitro fertilization cycles.
    Werner MD; Forman EJ; Hong KH; Franasiak JM; Molinaro TA; Scott RT
    Fertil Steril; 2014 Nov; 102(5):1312-7. PubMed ID: 25150393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody mapping of the antigenic surface of human thyrotropin and its subunits.
    Benkirane MM; Bon D; Costagliola S; Paolucci F; Darbouret B; Princé P; Carayon P
    Endocrinology; 1987 Sep; 121(3):1171-7. PubMed ID: 2441979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the direct action of luteinizing hormone-releasing hormone agonists at the testicular level in intact rats treated with an antiluteinizing hormone serum.
    Séguin C; Bélanger A; Labrie F; Hansel W
    Endocrinology; 1982 Feb; 110(2):524-30. PubMed ID: 6276140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A radioimmunoassay system for LH based on the antigenic similitude of LH with HCG: methodology and applications.
    Simionescu L; Dimitriu V; Aman E; Muşeţeanu P; Popa M; Marinescu I; Maximilian C
    Endocrinologie; 1985; 23(4):253-63. PubMed ID: 3841409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
    Hugues JN; Massé-Laroche E; Reboul-Marty J; Boîko O; Meynant C; Cédrin-Durnerin I
    Fertil Steril; 2011 Sep; 96(3):600-4. PubMed ID: 21880277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of pituitary alpha-subunit, beta-luteinizing hormone and prolactin messenger ribonucleic acid by gonadotropin-releasing hormone and estradiol in hypogonadal mice.
    Stanley HF; Lyons V; Obonsawin MC; Bennie J; Carroll S; Roberts JL; Fink G
    Mol Endocrinol; 1988 Dec; 2(12):1302-10. PubMed ID: 2464132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin-releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons.
    Lei ZM; Rao CV
    Mol Endocrinol; 1994 Aug; 8(8):1111-21. PubMed ID: 7997235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. II. Comparison of hMG and recombinant FSH.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(6):431-5. PubMed ID: 9459089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.